Evidence map›Paper›PMID 33407975›Full record

GuidelineCardiology in the young2021

COVID-19 FAQs in paediatric and congenital cardiology: AEPC position paper.

Skaiste Sendzikaite, Ruth Heying, Ornella Milanesi, Katarina Hanseus, Ina Michel-Behnke

Abstract readPractice Guideline
In one paragraph

Guideline in Cardiology in the young, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Remdesivir in COVID-19: pros and cons.Frontiers in pharmacology · 2026
    Review
  4. Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Review
  5. Article
  6. Article
  7. The Arrhythmogenic Face of COVID-19: Brugada ECG Pattern in SARS-CoV-2 Infection.Journal of cardiovascular development and disease · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Skaiste SendzikaiteClinic of Paediatrics, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania.ORCID https://orcid.org/0000-0002-0242-9586
Ruth HeyingDepartment of Paediatric and Congenital Cardiology, University Hospitals Leuven, Leuven, Belgium.ORCID https://orcid.org/0000-0003-0743-0823
Ornella MilanesiPaediatric Cardiology Unit, Department of Child and Woman's Health, University of Padua, Padua, Italy.
Katarina HanseusDepartment of Paediatric Cardiology, Skåne University Hospital, Lund, Sweden.
Ina Michel-BehnkeDepartment of Paediatric Cardiology, University Hospital of Children and Adolescent Medicine, Department of Paediatric Cardiology/Paediatric Heart Center, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-3131-573X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has had a huge influence in almost all areas of life, affecting societies, economics, and health care systems worldwide. The paediatric cardiology community is no exception. As the challenging battle with COVID-19 continues, professionals from the Association for the European Paediatric and Congenital Cardiology receive many questions regarding COVID-19 in a Paediatric and Congenital Cardiology setting. The aim of this paper is to present the AEPC position on frequently asked questions based on the most recent scientific data, as well as to frame a discussion on how to take care of our patients during this unprecedented crisis. As the times are changing quickly and information regarding COVID-19 is very dynamic, continuous collection of evidence will help guide constructive decision-making.

Indexed as

COVID-19 Drug TreatmentAdenosine MonophosphateAlanineAnti-Arrhythmia AgentsAnticoagulantsAntiviral AgentsArrhythmias, CardiacBrugada SyndromeCardiac Surgical ProceduresCardiologyCOVID-19Heart Defects, CongenitalHeart TransplantationHumansImmunologic FactorsInfectious Disease Transmission, VerticalAdenosine MonophosphateAlanineAnti-Arrhythmia AgentsAnticoagulantsAntiviral AgentsImmunologic FactorsremdesivirAEPCcongenital heart diseaseCOVID-19Kawasakimultisystem inflammatory syndromeSARS-Cov-2

Identifiers

PMID33407975
PMCPMC7900664

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.